Abbott Laboratories

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US0028241000
USD
107.27
2.78 (2.66%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
12,593.00
11,164.00
11,459.00
11,369.00
11,142.00
10,358.00
10,974.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
12,593.00
11,164.00
11,459.00
11,369.00
11,142.00
10,358.00
10,974.00
Raw Material Cost
5,289.00
5,242.00
5,328.00
5,451.00
5,266.00
4,914.00
5,376.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
299.00
104.00
135.00
121.00
135.00
134.00
152.00
Selling and Distribution Expenses
3,982.00
3,740.00
3,040.00
3,007.00
3,084.00
3,053.00
2,880.00
Other Expenses
58.30
66.30
58.60
62.70
58.30
56.90
57.60
Total Expenditure (Excl Depreciation)
10,153.00
9,749.00
9,089.00
9,206.00
9,068.00
8,670.00
8,984.00
Operating Profit (PBDIT) excl Other Income
2440
1415
2370
2163
2074
1688
1990
Other Income
130.00
93.00
160.00
222.00
280.00
224.00
206.00
Operating Profit (PBDIT)
1,912.00
2,311.00
3,322.00
3,176.00
3,131.00
2,668.00
3,003.00
Interest
299.00
104.00
135.00
121.00
135.00
134.00
152.00
Exceptional Items
-89.00
45.00
-37.00
-84.00
-69.00
0.00
-14.00
Gross Profit (PBDT)
7,304.00
5,922.00
6,131.00
5,918.00
5,876.00
5,444.00
5,598.00
Depreciation
0.00
803.00
792.00
791.00
777.00
756.00
807.00
Profit Before Tax
1,524.00
1,449.00
2,358.00
2,180.00
2,150.00
1,778.00
2,030.00
Tax
596.00
372.00
582.00
536.00
371.00
453.00
-7,199.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
928.00
1,077.00
1,800.00
1,600.00
1,800.00
1,300.00
9,195.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
928.00
1,077.00
1,800.00
1,600.00
1,800.00
1,300.00
9,195.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
928.00
1,077.00
1,800.00
1,600.00
1,800.00
1,300.00
9,195.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
0.00
52,061.00
52,130.00
50,954.00
50,565.00
48,811.00
47,664.00
Earnings per share (EPS)
0.53
0.62
1.03
0.91
1.03
0.74
5.29
Diluted Earnings per share
0.53
0.62
1.03
0.91
1.03
0.74
5.29
Operating Profit Margin (Excl OI)
14.15%
12.67%
20.68%
19.03%
18.61%
16.3%
18.13%
Gross Profit Margin
12.1%
20.17%
27.49%
26.13%
26.27%
24.46%
25.85%
PAT Margin
7.37%
9.65%
15.71%
14.07%
16.16%
12.55%
83.79%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2026 is 12.80% vs -2.57% in Mar 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2026 is -13.83% vs -40.17% in Mar 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2026 is -19.66% vs -29.85% in Mar 2026

stock-summary

Interest

QoQ Growth in quarter ended Jun 2026 is 187.50% vs -22.96% in Mar 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

Compare Quarterly Results Of Abbott Laboratories With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
12,593.00
11,005.00
1,588.00
14.43%
Other Operating Income
0.00
0.00
0.00
Total Operating income
12,593.00
11,005.00
1,588.00
14.43%
Raw Material Cost
5,289.00
6,560.00
-1,271.00
-19.38%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
299.00
450.00
-151.00
-33.56%
Selling and Distribution Expenses
3,982.00
2,138.00
1,844.00
86.25%
Other Expenses
58.30
-11.40
69.70
611.40%
Total Expenditure (Excl Depreciation)
10,153.00
9,034.00
1,119.00
12.39%
Operating Profit (PBDIT) excl Other Income
2,440.00
1,971.00
469.00
23.80%
Other Income
130.00
216.00
-86.00
-39.81%
Operating Profit (PBDIT)
1,912.00
2,923.00
-1,011.00
-34.59%
Interest
299.00
450.00
-151.00
-33.56%
Exceptional Items
-89.00
-3.00
-86.00
-2,866.67%
Gross Profit (PBDT)
7,304.00
4,445.00
2,859.00
64.32%
Depreciation
0.00
736.00
-736.00
-100.00%
Profit Before Tax
1,524.00
1,734.00
-210.00
-12.11%
Tax
596.00
70.00
526.00
751.43%
Provisions and contingencies
0
0
0.00
Profit After Tax
928.00
1,651.00
-723.00
-43.79%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
928.00
1,651.00
-723.00
-43.79%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
5.00
-5.00
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
928.00
1,656.00
-728.00
-43.96%
Equity Capital
0
0
0.00
Face Value
0.00
1.00
0.00
Reserves
0.00
51,934.00
-51,934.00
-100.00%
Earnings per share (EPS)
0.53
4.43
-3.90
-88.04%
Diluted Earnings per share
0.53
4.43
-3.90
-88.04%
Operating Profit Margin (Excl OI)
14.15%
17.91%
0.00
-3.76%
Gross Profit Margin
12.10%
22.44%
0.00
-10.34%
PAT Margin
7.37%
15.00%
0.00
-7.63%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,259.30 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 12.80% vs -2.57% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 13.02% vs 7.37% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 92.80 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is -13.83% vs -40.17% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -48.44% vs 38.78% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 178.20 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is -19.66% vs -29.85% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -37.50% vs 14.45% in Jun 2025

Quarterly - Interest
Interest 29.90 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 187.50% vs -22.96% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 121.48% vs -19.64% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 14.15%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025